Kiniksa Pharmaceuticals International, plc (KNSA)

NMS – Real Time Price. Currency in USD

78.11

+0.31 (0.40%)

At close: Aug 12, 2026, 3:59 PM EDT

78.15

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

07.08.2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time.

03.08.2026

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

KNSA lifted 2026 ARCALYST sales guidance as Q2 revenue surged, while advancing KPL-387 into Phase 3 to support its next growth driver.

Videos

No Data

There is no data to display

Kiniksa Pharmaceuticals International, plc (KNSA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Videos

No Data

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Videos

No Data

Search stocks

Kiniksa Pharmaceuticals International, plc (KNSA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Videos

No Data

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Videos

No Data